CN1141575C - 一种丹参药材的鉴别方法 - Google Patents
一种丹参药材的鉴别方法 Download PDFInfo
- Publication number
- CN1141575C CN1141575C CNB011199253A CN01119925A CN1141575C CN 1141575 C CN1141575 C CN 1141575C CN B011199253 A CNB011199253 A CN B011199253A CN 01119925 A CN01119925 A CN 01119925A CN 1141575 C CN1141575 C CN 1141575C
- Authority
- CN
- China
- Prior art keywords
- red sage
- sage root
- peaks
- red
- average
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 240000007164 Salvia officinalis Species 0.000 title claims abstract description 123
- 235000005412 red sage Nutrition 0.000 title claims abstract description 80
- 238000000034 method Methods 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 title abstract description 16
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims abstract description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229960003371 protocatechualdehyde Drugs 0.000 claims abstract description 20
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000013558 reference substance Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 7
- 238000010992 reflux Methods 0.000 claims abstract description 6
- 238000004811 liquid chromatography Methods 0.000 claims abstract description 4
- 238000010790 dilution Methods 0.000 claims abstract description 3
- 239000012895 dilution Substances 0.000 claims abstract description 3
- 235000017276 Salvia Nutrition 0.000 claims description 43
- 230000014759 maintenance of location Effects 0.000 claims description 20
- 239000012086 standard solution Substances 0.000 claims description 13
- 239000012088 reference solution Substances 0.000 claims description 9
- ZMMKVDBZTXUHFO-DDWIOCJRSA-M sodium;(2r)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate Chemical compound [Na+].[O-]C(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 ZMMKVDBZTXUHFO-DDWIOCJRSA-M 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 7
- 238000012850 discrimination method Methods 0.000 claims description 6
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 20
- 239000000126 substance Substances 0.000 abstract description 14
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 abstract description 7
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 abstract description 7
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 abstract description 7
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 7
- 239000012071 phase Substances 0.000 abstract description 6
- 239000007791 liquid phase Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 abstract 8
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 abstract 2
- 238000000691 measurement method Methods 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N tanshinone IIA Natural products C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 238000003556 assay Methods 0.000 description 5
- HYXITZLLTYIPOF-UHFFFAOYSA-N Tanshinone II Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)=CO2 HYXITZLLTYIPOF-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- AZEZEAABTDXEHR-UHFFFAOYSA-M sodium;1,6,6-trimethyl-10,11-dioxo-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-2-sulfonate Chemical compound [Na+].C12=CC=C(C(CCC3)(C)C)C3=C2C(=O)C(=O)C2=C1OC(S([O-])(=O)=O)=C2C AZEZEAABTDXEHR-UHFFFAOYSA-M 0.000 description 4
- 239000000470 constituent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003908 quality control method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- XYKZSUXWBGUGQV-UHFFFAOYSA-N 4,8-dimethylnaphtho[2,1-f][1]benzofuran-7,11-dione Chemical compound CC1=CC=CC2=C(C(C=3OC=C(C=3C3=O)C)=O)C3=CC=C21 XYKZSUXWBGUGQV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 244000194101 Ginkgo biloba Species 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- LJEROUHPDCFEGJ-VVTLTYDVSA-N (1r,3r,4s)-4,7,9-trihydroxy-1,3-dimethyl-3,4-dihydro-1h-benzo[g]isochromene-5,10-dione Chemical compound O=C1C2=CC(O)=CC(O)=C2C(=O)C2=C1[C@H](O)[C@@H](C)O[C@@H]2C LJEROUHPDCFEGJ-VVTLTYDVSA-N 0.000 description 1
- XDUXBBDRILEIEZ-LJQANCHMSA-N (6s)-6-(hydroxymethyl)-1,6-dimethyl-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCC[C@](C)(CO)C3=CC=C2C2=C1C(C)=CO2 XDUXBBDRILEIEZ-LJQANCHMSA-N 0.000 description 1
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 206010013709 Drug ineffective Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- XDUXBBDRILEIEZ-UHFFFAOYSA-N Tanshinone IIB Natural products O=C1C(=O)C2=C3CCCC(C)(CO)C3=CC=C2C2=C1C(C)=CO2 XDUXBBDRILEIEZ-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000029162 bladder disease Diseases 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- -1 phenol aldehyde Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011199253A CN1141575C (zh) | 2001-06-29 | 2001-06-29 | 一种丹参药材的鉴别方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011199253A CN1141575C (zh) | 2001-06-29 | 2001-06-29 | 一种丹参药材的鉴别方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1322951A CN1322951A (zh) | 2001-11-21 |
CN1141575C true CN1141575C (zh) | 2004-03-10 |
Family
ID=4663806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011199253A Expired - Fee Related CN1141575C (zh) | 2001-06-29 | 2001-06-29 | 一种丹参药材的鉴别方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1141575C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005088295A1 (fr) * | 2004-03-17 | 2005-09-22 | Tianjin Tasly Pharmaceutical Co., Ltd. | Procede de controle de qualite destine aux pilules a avaler composees de danshen |
CN100412546C (zh) * | 2004-03-17 | 2008-08-20 | 天津天士力制药股份有限公司 | 一种复方丹参滴丸指纹图谱的测定方法 |
CN100419423C (zh) * | 2004-10-15 | 2008-09-17 | 成都优他制药有限责任公司 | 独一味的质量控制方法 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1279903C (zh) * | 2002-08-23 | 2006-10-18 | 江苏康缘药业股份有限公司 | 含有银杏内酯的制剂及其制备工艺 |
CN100412545C (zh) * | 2002-12-23 | 2008-08-20 | 北京采瑞医药有限公司 | 一种治疗心脑血管疾病的复方丹参制剂的质量控制方法 |
CN100339706C (zh) * | 2003-06-19 | 2007-09-26 | 北京中医药大学 | 一种由栀子和三七制备的注射液的质量控制方法 |
CN1333248C (zh) * | 2003-07-14 | 2007-08-22 | 北京中医药大学 | 栀子药材和栀子半成品指纹图谱检测的质量控制方法 |
CN1308679C (zh) * | 2004-01-14 | 2007-04-04 | 江苏康缘药业股份有限公司 | 一种治疗小儿肺热咳嗽口服液的质量检测方法 |
CN100362345C (zh) * | 2005-07-21 | 2008-01-16 | 广州汉方现代中药研究开发有限公司 | 灵芝孢子或灵芝孢子油指纹图谱的建立方法 |
CN1963496B (zh) * | 2006-11-21 | 2012-09-05 | 浙江农林大学 | 消痛贴指纹图谱建立的方法及其标准指纹图谱 |
CN101266233B (zh) * | 2007-03-16 | 2011-02-23 | 株洲千金药业股份有限公司 | 一种单面针药材的鉴别方法 |
CN101040907B (zh) * | 2007-04-27 | 2011-01-05 | 上海现代中医药技术发展有限公司 | 扶正化瘀植物药中丹参原料指纹图谱质量检测方法 |
CN102370891A (zh) * | 2010-08-18 | 2012-03-14 | 浙江中医药大学 | 一种用hplc指纹图谱鉴别铁皮石斛真伪的方法 |
CN102866211A (zh) * | 2011-12-31 | 2013-01-09 | 山西振东泰盛制药有限公司 | 冠心宁注射液的指纹图谱的检测方法 |
CN102928538A (zh) * | 2012-11-23 | 2013-02-13 | 哈药集团中药二厂 | 丹参药材指纹图谱的建立方法及其标准指纹图谱 |
CN103149310B (zh) * | 2013-01-21 | 2015-05-20 | 贵州景峰注射剂有限公司 | 参芎葡萄糖注射液制剂的指纹图谱建立方法 |
CN103969356B (zh) * | 2013-02-02 | 2016-06-29 | 西安世纪盛康药业有限公司 | 一种丹参药材的指纹图谱的鉴别方法 |
CN105486787A (zh) * | 2015-12-04 | 2016-04-13 | 广东药学院 | 微乳色谱测定丹参有效成分指纹图谱的方法及应用 |
-
2001
- 2001-06-29 CN CNB011199253A patent/CN1141575C/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005088295A1 (fr) * | 2004-03-17 | 2005-09-22 | Tianjin Tasly Pharmaceutical Co., Ltd. | Procede de controle de qualite destine aux pilules a avaler composees de danshen |
CN100412546C (zh) * | 2004-03-17 | 2008-08-20 | 天津天士力制药股份有限公司 | 一种复方丹参滴丸指纹图谱的测定方法 |
CN100419423C (zh) * | 2004-10-15 | 2008-09-17 | 成都优他制药有限责任公司 | 独一味的质量控制方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1322951A (zh) | 2001-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1141575C (zh) | 一种丹参药材的鉴别方法 | |
CN1707260A (zh) | 当归、川芎中药材及其制剂指纹图谱的建立方法及标准指纹图谱 | |
CN107607649B (zh) | 一种黑骨藤的检测方法 | |
CN114152686B (zh) | 一种包含肉桂的中药复方的指纹图谱构建方法及其应用 | |
CN1857589A (zh) | 仙灵骨葆制剂中淫羊藿苷及朝藿定c的含量测定方法 | |
CN101078713A (zh) | 一种加入内标物的绞股蓝药材指纹图谱质量控制方法 | |
CN1315495C (zh) | 一种丹参提取物、其制备方法、药物制剂及检测方法 | |
CN102068553B (zh) | 一种治疗气滞血瘀所致乳癖制剂的hplc指纹图谱的构建方法 | |
CN103604898B (zh) | 益心舒制剂的指纹图谱检测方法 | |
CN106153805A (zh) | 一种元胡止痛胶囊指纹图谱的构建方法及其应用 | |
CN100381813C (zh) | 复方丹参滴丸质量控制方法 | |
CN109557233B (zh) | 一种白芍提取液中多指标成分含量的测定方法 | |
CN109142563A (zh) | 一种龟龄集uplc指纹图谱的构建方法及其应用 | |
CN100412546C (zh) | 一种复方丹参滴丸指纹图谱的测定方法 | |
CN1470868A (zh) | 丹参脂溶性成分指纹图谱的建立方法及其标准图谱 | |
CN1788748A (zh) | 一种含有原料药材丹参的注射剂及其质量控制方法 | |
CN1538170A (zh) | 抗病毒口服液指纹图谱检测技术 | |
CN103969356A (zh) | 一种丹参药材的指纹图谱的鉴别方法 | |
CN113341007A (zh) | 一种基于hplc特征图谱的枣仁安神胶囊全药味多成分含量测定方法 | |
CN102068566B (zh) | 治疗湿热黄疸的茵陈五疸丸的检测方法 | |
CN1314964C (zh) | 一种用指纹图谱控制板蓝根及其制剂质量和药效的方法 | |
CN110441414A (zh) | 金水六君煎指纹图谱的建立方法 | |
CN100515445C (zh) | 治疗广泛性焦虑症的中药制剂的质量检测方法 | |
CN100347540C (zh) | 参龙养血膏质量标准的检测方法 | |
CN1932508A (zh) | 半夏水溶性指纹图谱的建立方法及其标准指纹图谱 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TIANJIN DISHILI INVESTMENT STOCK GROUP CO.,LTD. Free format text: FORMER NAME OR ADDRESS: JINSHILI MEDICINE RESEARCH +. DEVELOPMENT CO., LTD., TIANJIN |
|
CP03 | Change of name, title or address |
Address after: 300402 Tianjin science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee after: Dishili Investment Holding Group Co., Ltd., Tianjin Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Jinshili Medicine Research &. Development Co., Ltd., Tianjin |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160415 Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin science and Technology Park of Beichen Xinyi Road Liaohe Road No. 1 white Patentee before: Dishili Investment Holding Group Co., Ltd., Tianjin |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300410 Tianjin city Beichen District Huaihe road and road intersection Dingjiang tianzhijiao Park forensic Center for Intellectual Property Department Patentee before: Tasly Pharmaceutical Group Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040310 Termination date: 20190629 |